Application Nr Approved Date Route Status External Links
NDA208700 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lutathera Is Indicated For The Treatment Of Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (Gep-Nets), Including Foregut, Midgut, And Hindgut Neuroendocrine Tumors In Adults. Lutathera Is A Radiolabeled Somatostatin Analog Indicated For The Treatment Of Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (Gep-Nets), Including Foregut, Midgut, And Hindgut Neuroendocrine Tumors In Adults.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lutetium Oxodotreotide Lu-177

Comments